Exchange: OTC·Updated 12:25 PM EDT

VCNXVaccinex Inc

$1.18
$0.31
(35.63%)
Today
Mkt Cap$2.33M
Vol2,616.00
News
all
press releases
Micro Cap Biotech Secures $60M to Advance Alzheimer’s Treatment, Shares Surge
Alzheimer’s disease is the most common form of dementia, primarily affecting people over the age of 65. It progressively damages brain cells through the buildup of abnormal proteins (known as plaques and tangles) which destroy neurons and interfere with communication throughout the brain.Developing effective prevention or treatment remains extremely challenging because Alzheimer’s is driven by multiple interacting factors, including inflammation, genetics, and possibly infections, rather than a single cause. In addition, many therapies struggle to reach the brain due to its ...
AllPennyStocks
Micro Cap Biotech Secures $60M to Advance Alzheimer’s Treatment, Shares Surge
Alzheimer’s disease is the most common form of dementia, primarily affecting people over the age of 65. It progressively damages brain cells through the buildup of abnormal proteins (known as plaques and tangles) which destroy neurons and interfere with communication throughout the brain.Developing effective prevention or treatment remains extremely challenging because Alzheimer’s is driven by multiple interacting factors, including inflammation, genetics, and possibly infections, rather than a single cause. In addition, many therapies struggle to reach the brain due to its ...
AllPennyStocks
Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens
The Rochester, N.Y.-based firm said it will present ‘promising’ new efficacy and safety data for the treatment of Alzheimer’s disease later this month.
Stocktwits
<
...
1
>